Clozapine dose-concentration relationships in plasma, hair and sweat specimens of schizophrenic patients

Forensic Science International

Volumn 107, Issue 1-3, 2000, Pages 289-300

  Cirimele, Vincent ^a   Kintz, Pascal ^a   Gosselin, Olivier ^b   Ludes, Bertrand ^a  

^a INSTITUT DE MÉDECINE LÉGALE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Analytical procedures; Clozapine; Hair; Monitoring; Sweat

Indexed keywords

CLOZAPINE;

CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG MONITORING; GAS CHROMATOGRAPHY; HAIR ANALYSIS; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SWEAT;

EID: 0033966529     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0379-0738(99)00172-3     Document Type: Conference Paper

References (36)

1. Baumgartner W.A., Hill V.A., Blahd W.H. Hair analysis for drugs of abuse. J. Forensic Sci. 34:1989;1433-1453.
2. Uematsu T., Miyazawa N., Nakashima M. The measurement of haloperidol and reduced haloperidol in hair as an index of dosage history. Br. J. Clin. Pharmacol. 40:1990;581-584.
3. Moeller M.R., Fey P., Wennig R. Simultaneous determination of drugs of abuse (opiates, cocaine and amphetamines) in human hair by GC-MS and its application to a methadone treatment program. Forensic Sci. Int. 63:1993;185-206.
4. Kintz P., Brenneisen R., Bundeli P., Mangin P. Sweat testing for heroin and metabolites in a heroin maintenance program. Clin. Chem. 43:1997;736-739.
5. Kintz P., Tracqui A., Jamey C., Mangin P. Detection of codeine and phenobarbital in sweat collected with a sweat patch. J. Anal. Toxicol. 20:1996;197-201.
6. Philipps M. Sweat-patch testing detects inaccurate self-reports of alcohol consumption. Alcohol Clin. Exp. Res. 8:1984;51-53.
7. Burns M., Baselt R.C. Monitoring drug use with a sweat patch: an experiment with cocaine. J. Anal. Toxicol. 19:1995;41-48.
8. Cone E.J., Hillsgrove M.J., Jenkins A.J., Keenam R.M., Darwin W.D. Sweat testing for heroin, cocaine and metabolites. J. Anal. Toxicol. 19:1995;298-305.
9. Kintz P. A comparison between urine, sweat and hair. Ther. Drug Monit. 18:1996;450-455.
10. Kintz P., Edel Y., Tracqui A., Mangin P. Sweat testing in opioid users with a sweat patch. J. Anal. Toxicol. 20:1996;393-397.
11. Kintz P., Tracqui A., Marzullo C., Darreye A., Tremeau F., Greth P., Ludes B. Stereoselective excretion of methadone in sweat as monitored by liquid chromatography-ion spray-mass spectrometry. Ther. Drug Monit. 20:1998;35-40.
12. Parnas J., Flachs H., Gram L., Würtz-Jorgensen A. Excretion of antiepileptic drugs in sweat. Acta Neurol. Scandinav. 58:1978;197-204.
13. Ackenheil M. Clozapine - pharmacokinetic investigations and biological effects in man. Psychopharmacology. 99:1989;32-37.
14. Baldessarini R.J., Frankenburg F.R. Clozapine: a novel antipsychotic agent. New Engl. J. Med. 324:1991;746-754.
15. Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic. Arch. Gen. Psychiatry. 45:1988;789-796.
16. Meltzer H.Y. New drugs for the treatment of schizophrenia. Schizophrenia. 16:1993;365-385.
17. Barbui C., Campomori A., Bonati M. Clozapine and blood dyscrasias different from agranulocytosis. Can. J. Psychiatry. 42:1997;981-982.
18. Krupp P., Barnes P. Clozapine-associated agranulocytosis: risk and aetiology. Br. J. Psychiatry. 160:1992;38-40.
19. Heipertz R., Pilz H., Beckers W. Serum concentrations of clozapine determined by nitrogen selective gas chromatography. Arch. Toxicol. 37:1977;313-318.
20. Hasegawa M., Gutierrez-Esteinou R., Way L., Meltzer H.Y. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking. J. Clin. Psychopharmacol. 13:1993;383-390.
21. Olesen O.V., Poulsen B. On-line fully automated determination of clozapine and desmethylclozapine in human serum by solid-phase extraction on exchangeable cartridges and liquid chromatography using a methanol buffer mobile phase on unmodified silica. J. Chromatogr. B. 622:1993;39-46.
22. Volpicelli S.A., Centorrino F., Puopolo P.R., Kando J., Frankenburg F.R., Baldessarini R.J., Flood J.G. Determination of clozapine, norclozapine and clozapine-N-oxide in serum by liquid chromatography. Clin. Chem. 39:1993;1656-1659.
23. Perry P.J., Miller D.D., Arndt S.V., Cadoret R.J. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Am. J. Psychiatry. 148:1991;231-235.
24. Owen J.A., Delva N.J., Lawson J.S. Clozapine concentrations and clinical response in schizophrenic patients. Am. J. Psychiatry. 149:1992;1120-1121.
25. Simpson G.M., Cooper T.A. Clozapine plasma levels and convulsions. Am. J. Psychiatry. 135:1978;99-100.
26. Pickar D., Owen R.R., Litman R.E., Konicki P.E., Gutierrez R., Rapaport M.H. Clinical and biological response to clozapine in patients with schizophrenia. Arch. Gen. Psychiatry. 49:1992;345-353.
27. Zeren W., Minglian L., Peipei X., Yanlin Z. Determination of clozapine and its metabolites in serum and urine by reversed-phase HPLC. Biomed. Chromatogr. 1:1986;53-57.
28. Haring C., Humpel C., Auer B., Saria A., Barnas A., Fleischhacker W., Hinterhuber H. Clozapine plasma levels determined by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 428:1988;160-166.
29. Humpel C., Haring C., Saria A. Rapid and sensitive determination of clozapine in human plasma using high-performance liquid chromatography and amperometric detection. J. Chromatogr. 491:1989;235-239.
30. Wilhelm D., Kemper A. High-performance liquid chromatography procedure for the determination of clozapine, haloperidol, droperidol and several benzodiazepines in plasma. J. Chromatogr. 525:1990;218-224.
31. Weigmann H., Hiemke C. Determination of clozapine and its major metabolites in human serum using automated solid-phase extraction and subsequent isocratic high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 583:1992;209-216.
32. Kintz P., Cirimele V., Gosselin O., Edel Y., Mangin P. Testing human hair for clozapine. Ann. Biol. Clin. 54:1996;315-316.
33. Kutschera J., Zahlsen K., Hamnes A., Nilsen O.G., Aamo T.O. Determination of clozapine and its active metabolite N-desmethylclozapine in hair of schizophrenic patients. Poster presented at the First European Meeting on Hair Analysis, Genova, Italy, June 17-19 :1996.
34. Tracqui A., Kintz P., Mangin P. Systematic toxicological analysis using HPLC/DAD. J. Forensic Sci. 40:1995;254-262.
35. Tracqui A., Kintz P., Mangin P. Hair analysis: a worthless tool for therapeutic compliance monitoring. Forensic Sci. Int. 70:1995;183-189.
36. Préterre P.H. Clozapinémie et ajustement thérapeutique. L'Encéphale. 3:1995;53-57.